188 related articles for article (PubMed ID: 10821822)
1. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
Lim HW; De Windt LJ; Steinberg L; Taigen T; Witt SA; Kimball TR; Molkentin JD
Circulation; 2000 May; 101(20):2431-7. PubMed ID: 10821822
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy.
Shimoyama M; Hayashi D; Takimoto E; Zou Y; Oka T; Uozumi H; Kudoh S; Shibasaki F; Yazaki Y; Nagai R; Komuro I
Circulation; 1999 Dec; 100(24):2449-54. PubMed ID: 10595959
[TBL] [Abstract][Full Text] [Related]
3. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats.
Zhang W; Kowal RC; Rusnak F; Sikkink RA; Olson EN; Victor RG
Circ Res; 1999 Apr; 84(6):722-8. PubMed ID: 10189360
[TBL] [Abstract][Full Text] [Related]
4. Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy.
Saito T; Fukuzawa J; Osaki J; Sakuragi H; Yao N; Haneda T; Fujino T; Wakamiya N; Kikuchi K; Hasebe N
J Mol Cell Cardiol; 2003 Sep; 35(9):1153-60. PubMed ID: 12967638
[TBL] [Abstract][Full Text] [Related]
5. [Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension].
Shimoyama M; Hayashi D; Zou Y; Takimoto E; Mizukami M; Monzen K; Yazaki Y; Nagai R; Komuro I
J Cardiol; 2001 Feb; 37(2):114-8. PubMed ID: 11255695
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension.
Shimoyama M; Hayashi D; Zou Y; Takimoto E; Mizukami M; Monzen K; Kudoh S; Hiroi Y; Yazaki Y; Nagai R; Komuro I
Circulation; 2000 Oct; 102(16):1996-2004. PubMed ID: 11034951
[TBL] [Abstract][Full Text] [Related]
7. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin.
Ding B; Price RL; Borg TK; Weinberg EO; Halloran PF; Lorell BH
Circ Res; 1999 Apr; 84(6):729-34. PubMed ID: 10189361
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H
Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.
Zou Y; Hiroi Y; Uozumi H; Takimoto E; Toko H; Zhu W; Kudoh S; Mizukami M; Shimoyama M; Shibasaki F; Nagai R; Yazaki Y; Komuro I
Circulation; 2001 Jul; 104(1):97-101. PubMed ID: 11435345
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload.
Hill JA; Karimi M; Kutschke W; Davisson RL; Zimmerman K; Wang Z; Kerber RE; Weiss RM
Circulation; 2000 Jun; 101(24):2863-9. PubMed ID: 10859294
[TBL] [Abstract][Full Text] [Related]
11. Effects of combination of irbesartan and perindopril on calcineurin expression and sarcoplasmic reticulum Ca2+-ATPase activity in rat cardiac pressure-overload hypertrophy.
Jiang QJ; Xu G; Mao FF; Zhu YF
J Zhejiang Univ Sci B; 2006 Mar; 7(3):228-34. PubMed ID: 16502511
[TBL] [Abstract][Full Text] [Related]
12. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
13. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
[TBL] [Abstract][Full Text] [Related]
14. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
15. Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling.
Lu Y; Zhao M; Liu JJ; He X; Yu XJ; Liu LZ; Sun L; Chen LN; Zang WJ
J Cell Mol Med; 2017 Sep; 21(9):2106-2116. PubMed ID: 28296184
[TBL] [Abstract][Full Text] [Related]
16. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.
Zhang W
Cardiovasc Res; 2002 Feb; 53(2):294-303. PubMed ID: 11827679
[TBL] [Abstract][Full Text] [Related]
17. Electrical remodeling in pressure-overload cardiac hypertrophy: role of calcineurin.
Wang Z; Kutschke W; Richardson KE; Karimi M; Hill JA
Circulation; 2001 Oct; 104(14):1657-63. PubMed ID: 11581145
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin activation is not necessary for Doxorubicin-induced hypertrophy in H9c2 embryonic rat cardiac cells: involvement of the phosphoinositide 3-kinase-Akt pathway.
Merten KE; Jiang Y; Feng W; Kang YJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):934-40. PubMed ID: 16926266
[TBL] [Abstract][Full Text] [Related]
19. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
[TBL] [Abstract][Full Text] [Related]
20. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
